Drugs / DPT-IPV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT02140047 Background | Apr 2014 → Jan 2015 | haemophilus infectious disease | Tanabe Pharma Corporation | Completed | No outcome recorded |
| Phase 3 | NCT02992925 Comparator | Nov 2016 → Dec 2017 | — | Tanabe Pharma Corporation | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DPT-IPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02140047 ↗ |
| Modality | Vaccine | “DPT-IPV” NCT02992925 ↗ |
| Route | Subcutaneous | “subcutaneous injection” NCT02992925 ↗ |